7506

    532300

    WOCKPHARMA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    WOCKHARDT LIMITED Share Price Today

    WOCKHARDT LIMITED is currently trading at ₹1950, down by ₹12.69 from the previous close. The stock touched an intraday high of ₹1984.70 and a low of ₹1876.60 during the latest trading session. Over the past one year, WOCKHARDT LIMITED has delivered a return of 17.0%, while the stock has declined 8.83% in the last one month.

    WOCKHARDT LIMITED performance

    Today’s low Today’s high
    ₹ 1876.60 ₹ 1984.70
    ₹ 1948.80
    52 week low 52 week high
    ₹ 1086.70 ₹ 2422.30
    ₹ 1948.80
    Open Price ₹ 1972.00
    Prev. Close ₹ 1962.70
    Volume (Shares) 784689.00
    Total traded value ₹ 15292.01
    Upper Circuit ₹ 2355.20
    Lower Circuit ₹ 1570.20
    info

    Investment Returns

    Over 1 Month -8.83% Over 3 Months 54.83% Over 6 Months 37.93% Over 1 Year 17.00%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    WOCKHARDT LIMITED fundamentals


    • Market cap (Cr) 31,666.50
    • P/E Ratio (TTM) 100.53
    • Beta 0.85
    • Book Value / share 189.80
    • Return on equity 0.00%
    • EPS (TTM) 17.97
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 167.00
    info icon alternate text
    • Market cap (Cr) 31,651.00
    • P/E Ratio (TTM) 100.53
    • Beta 0.73
    • Book Value / share 189.80
    • Return on equity 0.00%
    • EPS (TTM) 17.97
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 167.00
    info icon alternate text

    WOCKHARDT LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 516.00
    Operating Expense 439.00
    Net Profit 167.00
    Net Profit Margin (%) 32.36
    Earnings Per Share (EPS) 10.29
    EBITDA 251.00
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 430.00
    Operating Expense 419.00
    Net Profit 28.00
    Net Profit Margin (%) 6.51
    Earnings Per Share (EPS) 1.73
    EBITDA 130.00
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 380.00
    Operating Expense 356.00
    Net Profit 54.00
    Net Profit Margin (%) 14.21
    Earnings Per Share (EPS) 3.26
    EBITDA 143.00
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 413.00
    Operating Expense 369.00
    Net Profit 69.00
    Net Profit Margin (%) 16.70
    Earnings Per Share (EPS) 4.25
    EBITDA 156.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 355.00
    Operating Expense 329.00
    Net Profit 40.00
    Net Profit Margin (%) 11.26
    Earnings Per Share (EPS) 2.47
    EBITDA 120.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 1739.00
    Operating Expense 1584.00
    Net Profit 317.00
    Net Profit Margin (%) 18.22
    Earnings Per Share (EPS) 19.54
    EBITDA 679.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 1402.00
    Operating Expense 1469.00
    Net Profit -12.00
    Net Profit Margin (%) -0.85
    Earnings Per Share (EPS) -0.76
    EBITDA 355.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 1154.00
    Operating Expense 1603.00
    Net Profit -422.00
    Net Profit Margin (%) -36.56
    Earnings Per Share (EPS) -29.27
    EBITDA -9.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 1072.00
    Operating Expense 1417.00
    Net Profit -466.00
    Net Profit Margin (%) -43.47
    Earnings Per Share (EPS) -32.40
    EBITDA -98.00
    Effective Tax Rate (%) 9.16
    Particulars MAR 2022 (Values in Cr)
    Revenue 1372.00
    Operating Expense 1594.00
    Net Profit -140.00
    Net Profit Margin (%) -10.20
    Earnings Per Share (EPS) -11.62
    EBITDA 260.00
    Effective Tax Rate (%) 23.91
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 268.70
    ROE % -1.48
    ROCE % 3.87
    Total Debt to Total Equity 0.57
    EBITDA Margin 15.11
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 218.12
    ROE % -12.34
    ROCE % -0.86
    Total Debt to Total Equity 0.68
    EBITDA Margin 6.22
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 232.92
    ROE % -9.21
    ROCE % -0.45
    Total Debt to Total Equity 0.61
    EBITDA Margin 8.45
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 267.29
    ROE % -3.06
    ROCE % 1.15
    Total Debt to Total Equity 0.67
    EBITDA Margin 9.85
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 306.91
    ROE % 27.45
    ROCE % -2.85
    Total Debt to Total Equity 1.03
    EBITDA Margin 2.55
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 170.56
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.86
    EBITDA Margin 25.32
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 116.62
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.17
    EBITDA Margin -0.78
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 121.74
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.02
    EBITDA Margin 12.78
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 153.61
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.07
    EBITDA Margin 18.95
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 146.00
    ROE % 56.52
    ROCE % -7.40
    Total Debt to Total Equity 1.71
    EBITDA Margin -9.83
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 191.00
    Total Assets 8135.00
    Total Liabilities 8135.00
    Total Equity 4657.00
    Share Outstanding 16
    Price to Book Ratio 8.35
    Return on Assets (%) -0.57
    Return on Capital (%) -0.72
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 529.00
    Total Assets 7649.00
    Total Liabilities 7649.00
    Total Equity 3662.00
    Share Outstanding 15
    Price to Book Ratio 5.00
    Return on Assets (%) -6.05
    Return on Capital (%) -8.02
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 124.00
    Total Assets 7683.00
    Total Liabilities 7683.00
    Total Equity 3662.00
    Share Outstanding 14
    Price to Book Ratio 1.26
    Return on Assets (%) -7.27
    Return on Capital (%) -10.07
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 406.00
    Total Assets 8243.00
    Total Liabilities 8243.00
    Total Equity 4202.00
    Share Outstanding 14
    Price to Book Ratio 1.72
    Return on Assets (%) -2.96
    Return on Capital (%) -4.02
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 292.00
    Total Assets 7774.00
    Total Liabilities 7774.00
    Total Equity 3759.00
    Share Outstanding 11
    Price to Book Ratio 2.84
    Return on Assets (%) 8.82
    Return on Capital (%) 11.26
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 113.00
    Total Assets 5408.00
    Total Liabilities 5408.00
    Total Equity 2763.00
    Share Outstanding 16
    Price to Book Ratio 8.35
    Return on Assets (%) -0.22
    Return on Capital (%) -0.28
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 486.00
    Total Assets 4868.00
    Total Liabilities 4868.00
    Total Equity 1796.00
    Share Outstanding 15
    Price to Book Ratio 5.00
    Return on Assets (%) -8.66
    Return on Capital (%) -11.77
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 37.00
    Total Assets 4732.00
    Total Liabilities 4732.00
    Total Equity 1753.00
    Share Outstanding 14
    Price to Book Ratio 1.26
    Return on Assets (%) -9.84
    Return on Capital (%) -13.82
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 207.00
    Total Assets 5798.00
    Total Liabilities 5798.00
    Total Equity 2212.00
    Share Outstanding 14
    Price to Book Ratio 1.72
    Return on Assets (%) -2.41
    Return on Capital (%) -3.68
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 138.00
    Total Assets 4895.00
    Total Liabilities 4895.00
    Total Equity 1606.00
    Share Outstanding 11
    Price to Book Ratio 2.84
    Return on Assets (%) 12.11
    Return on Capital (%) 18.42
    Particulars MAR 2025 (Values in Cr)
    Net Income -16.00
    Cash from Operations -53.00
    Cash from Investing -783.00
    Cash from Financing 409.00
    Net change in Cash -396.00
    Free Cash Flow 41.00
    Particulars MAR 2024 (Values in Cr)
    Net Income -420.00
    Cash from Operations 249.00
    Cash from Investing -137.00
    Cash from Financing 334.00
    Net change in Cash 416.00
    Free Cash Flow 308.00
    Particulars MAR 2023 (Values in Cr)
    Net Income -624.00
    Cash from Operations 164.00
    Cash from Investing -125.00
    Cash from Financing -315.00
    Net change in Cash -287.00
    Free Cash Flow 206.00
    Particulars MAR 2022 (Values in Cr)
    Net Income -411.00
    Cash from Operations 510.00
    Cash from Investing -201.00
    Cash from Financing -71.00
    Net change in Cash 141.00
    Free Cash Flow 628.00
    Particulars MAR 2021 (Values in Cr)
    Net Income 916.00
    Cash from Operations -170.00
    Cash from Investing 1470.00
    Cash from Financing -1171.00
    Net change in Cash 12.00
    Free Cash Flow -89.00
    Particulars MAR 2025 (Values in Cr)
    Net Income -12.00
    Cash from Operations -41.00
    Cash from Investing -900.00
    Cash from Financing 486.00
    Net change in Cash -428.00
    Free Cash Flow 0.00
    Particulars MAR 2024 (Values in Cr)
    Net Income -422.00
    Cash from Operations 188.00
    Cash from Investing -75.00
    Cash from Financing 346.00
    Net change in Cash 459.00
    Free Cash Flow 190.00
    Particulars MAR 2023 (Values in Cr)
    Net Income -513.00
    Cash from Operations 76.00
    Cash from Investing -3.00
    Cash from Financing -236.00
    Net change in Cash -168.00
    Free Cash Flow 76.00
    Particulars MAR 2022 (Values in Cr)
    Net Income -184.00
    Cash from Operations -14.00
    Cash from Investing -244.00
    Cash from Financing 430.00
    Net change in Cash 93.00
    Free Cash Flow 38.00
    Particulars MAR 2021 (Values in Cr)
    Net Income 861.00
    Cash from Operations -452.00
    Cash from Investing 1014.00
    Cash from Financing -480.00
    Net change in Cash -29.00
    Free Cash Flow -435.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.81 13.14 1.53 243.77 23.12 38.85
    BLISS GVS PHARMA LTD. 524.85 42.60 4.66 5566.36 118.35 552.90
    CIPLA LTD 1456.95 30.92 3.41 117699.02 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 354.50 15.64 2.56 1043.33 256.40 399.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.81 22.24 4.09 243.77 23.12 38.85
    AMRUTAJAN HEALTH LTD 549.45 24.63 4.29 1588.49 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8216.55 107.31 23.53 20541.38 7630.00 9850.00
    BLISS GVS PHARMA LTD. 524.85 56.62 4.81 5566.36 118.35 552.90

    WOCKHARDT LIMITED shareholding pattern

    Holding
    32.86%
    49.08%
    7.08%
    10.96%
    18.82%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    WOCKHARDT LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1948.80 -0.70 redarrow
    red-green-graph indicator
    7 Bearish
    9 Bullish
    • 5 Days 1961.30
    • 26 Days 1896.80
    • 10 Days 1962.10
    • 50 Days 1774.30
    • 12 Days 1958.40
    • 100 Days 1629.60
    • 20 Days 1927.80
    • 200 Days 1522.80
    1968.90 PIVOT
    First Support 1943.80 First Resistance 1987.80 Second Support 1924.90 Second Resistance 2012.90 Third Support 1899.80 Third Resistance 2031.80
    RSI 57.12 ADX 34.27 MACD 61.62 Williams % R -55.21 Commodity Channel Index (CCI) 0.34
    Date 2026-07-01 Week 311102.00 Same Day 217231.00 Month 637849.00
    1 Year 0.85 3 Year 1.20
    Over 1 Month
    -8.83% down
    Over 1 Year
    17.00% down
    Over 3 Months
    54.83% down
    Over 3 Years
    102.26% down
    Over 6 Months
    37.93% down
    Over 5 Years
    31.54% down

    WOCKHARDT LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    17 Nov 2016 10.0 Interim 19 Nov 2016 Equity shares
    13 Nov 2014 20.0 Interim 15 Nov 2014 Equity shares
    17 Feb 2014 5.0 Interim 2 19 Feb 2014 Equity shares
    07 Nov 2013 5.0 Interim 08 Nov 2013 Equity shares
    22 Aug 2013 5.0 Final 24 Aug 2013 Equity shares
    17 Apr 2008 2.5 Final 22 Apr 2008 Equity shares
    26 Oct 2007 8.75 Interim 29 Oct 2007 Equity shares
    22 Mar 2007 5.0 Interim 23 Mar 2007 Equity shares
    21 Jun 2006 0.0 Final 23 Jun 2006 Equity shares
    Ex-Date Ex-Bonus Ratio
    07 May 2004 28 Apr 2004 1:2
    Ex-Date Old FV NEW FV Record Date
    28 Apr 2004 10.0 5.0 07 May 2004
    Dividend date Dividend amount Dividend type Record date Instrument type
    17 Nov 2016 10.0 Interim 19 Nov 2016 Equity shares
    13 Nov 2014 20.0 Interim 15 Nov 2014 Equity shares
    17 Feb 2014 5.0 Interim 2 19 Feb 2014 Equity shares
    07 Nov 2013 5.0 Interim 08 Nov 2013 Equity shares
    22 Aug 2013 5.0 Final 24 Aug 2013 Equity shares
    17 Apr 2008 2.5 Final 22 Apr 2008 Equity shares
    26 Oct 2007 8.75 Interim 29 Oct 2007 Equity shares
    22 Mar 2007 5.0 Interim 23 Mar 2007 Equity shares
    21 Jun 2006 0.0 Final 23 Jun 2006 Equity shares
    Ex-Date Ex-Bonus Ratio
    07 May 2004 28 Apr 2004 1:2
    Ex-Date Old FV NEW FV Record Date
    28 Apr 2004 10.0 5.0 07 May 2004

    Top Gainers

    Top Losers

    Wockhardt Limited share results highlights 

    Wockhardt Limited reported consolidated sales of ₹738 crores in Q1 FY26 compared to ₹739 crores in Q1 FY25, while total expenses for the quarter increased to ₹666 crores from ₹648 crores. Net loss in Q1 FY26 was ₹108 crores compared to ₹16 crores in Q1 FY25. Earnings per Share (EPS) in Q1 FY26 were negative ₹5.54 compared to negative ₹0.91 in Q1 FY25.   

    Wockhardt Limited annual reports 

    The consolidated sales in FY25 were ₹3,012 Crore compared with ₹2,798 Crore in FY24. Expenses amounted to ₹2,619 Crore in FY25 compared with ₹2,707 Crore in FY24. Net loss in FY25 was ₹57 Crore compared with ₹472 Crore in FY24. Earnings per share was negative ₹2.89 in FY25 versus negative ₹30.18 in FY24.  

    Wockhardt Limited dividend 

    Wockhardt Limited has not announced any dividend since 2016.

    Additional FAQs

    1. Who is the CEO of Wockhardt Ltd?

    Dr. Habil Khorakiwala is the Founder and Chairman of Wockhardt Ltd, while Dr. Murtaza Khorakiwala is the company’s Managing Director.

     

    2. When was Wockhardt Ltd established?

    Wockhardt Ltd was established in 1967 and has grown into a global pharmaceutical and biotechnology company with a strong focus on innovation.

     

    3. What factors influence the Wockhardt Share Price?

    Wockhardt’s share price is influenced by factors such as product pipeline development, regulatory approvals, operational performance, and demand for its pharmaceutical offerings globally.

     

    4. Is Wockhardt Ltd debt free?

    No, Wockhardt Ltd is not debt free, as the company utilises financing to support its research, development, and expansion activities.

     

    5. What is the CAGR of Wockhardt Share?

    The CAGR of Wockhardt’s share is 5% over 10 years, 41% over 5 years, and 50% over 3 years.

     

    6. How has the Wockhardt Share Price performed over the past year?

    Over the past year, Wockhardt’s share price has seen a meteoric rise of 292%, driven by positive developments in its product offerings and improved financial performance.

     

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Wockhardt Ltd?

    Answer Field

    Wockhardt Ltd share price is for NSE ₹ 1,950.00 & for BSE ₹ 1,949.10 as on Jul 02 2026 03:30 PM.

    What is the Market Cap of Wockhardt Ltd Share?

    Answer Field

    The market cap of Wockhardt Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 02 2026 03:30 PM.

    What is the 52 Week High and Low of Wockhardt Ltd?

    Answer Field

    The 52 Week High and Low of Wockhardt Ltd for NSE is ₹ 2,422.30 and ₹ 1,086.70 and for BSE is ₹ 2,420.00 and ₹ 1,086.80.

    What is 1 year return for Wockhardt Ltd?

    Answer Field

    The 1 year returns on the stock has been 17.00%.

    What is the P/E Ratio of Wockhardt Ltd Share?

    Answer Field

    As on Jul 02 2026 03:30 PM the price-to-earnings (PE) ratio for Wockhardt Ltd share is 100.53.

    What is the PB ratio of Wockhardt Ltd Share?

    Answer Field

    As on Jul 02 2026 03:30 PM, the price-to-book (PB) ratio for Wockhardt Ltd share is 189.80.

    How to Buy Wockhardt Ltd Share?

    Answer Field

    You can trade in Wockhardt Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Wockhardt Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Wockhardt Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Wockhardt Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    Who is the CEO of Wockhardt Ltd?

    Answer Field

    Dr. Habil Khorakiwala is the Founder and Chairman of Wockhardt Ltd, while Dr. Murtaza Khorakiwala is the company’s Managing Director.

    When was Wockhardt Ltd established?

    Answer Field

    Wockhardt Ltd was established in 1967 and has grown into a global pharmaceutical and biotechnology company with a strong focus on innovation.

    What factors influence the Wockhardt Share Price?

    Answer Field

    Wockhardt’s share price is influenced by factors such as product pipeline development, regulatory approvals, operational performance, and demand for its pharmaceutical offerings globally.

    Is Wockhardt Ltd debt free?

    Answer Field

    No, Wockhardt Ltd is not debt free, as the company utilises financing to support its research, development, and expansion activities.

    What is the CAGR of Wockhardt Share?

    Answer Field

    The CAGR of Wockhardt’s share is 5% over 10 years, 41% over 5 years, and 50% over 3 years.

    How has the Wockhardt Share Price performed over the past year?

    Answer Field

    Over the past year, Wockhardt’s share price has seen a meteoric rise of 292%, driven by positive developments in its product offerings and improved financial performance.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |